View More Recent Stories

Aug 7, 2024 04:04PM Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS
Jul 16, 2024 02:06PM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)
Jun 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Allogene (ALLO)
View More Recent Stories